Insights

Payers Have Limited Solutions To Manage GLP-1s For Obesity Key Points GLP‑1 coverage for obesity remains limited, with only 39% of payers offering it.

Why Your PBM Partnership Needs More Than a Strong Start Key Points While procurement and implementation activities are important, active PBM vendor management is…

A Snippet From Our GLP-1 Spotlight Webinar Key Points Employers tend to view obesity as a chronic condition, while health plans lean slightly toward…

PSG announces the results of the industry’s go-to report on pharmacy benefit manager (PBM) customer satisfaction, grounded in real-world perspectives from a wide range…

Immediate Post-Procurement Considerations for Employers Key Points A successful PBM implementation is just as critical as procurement and directly impacts member experience and financial…

Leveraging Audits To Build Strategic Advantage Key Points Auditing is essential for navigating pharmacy benefit complexity and ensuring strategic oversight. Key events like vendor…

DALLAS, TX – August 5, 2025 – Pharmaceutical Strategies Group (“PSG”), an EPIC company, released the Artemetrx State of Specialty Spend…

PSG announces the results of the industry’s go-to report on specialty drug spend and trend. With specialty drug costs remaining a top concern…

Ensure Your Consultant and Procurement are Best-in-Class Ten to fifteen years ago, pharmacy benefit manager (PBM) procurements were relatively simple: plan sponsors would go…